Cholesterol-lowering drug being tested at Penn Medicine to help fight COVID-19

ABC 30 | August 11, 2021

Two different studies in laboratories found the drug Fenofibrate reduced COVID-19 infection by up to 70%. Doctors say if this works in actual patients, it could have a major impact by helping to slow the spread of the virus and save lives.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!